MolecuLayer

Revolutionizing Drug Discovery

MolecuLayer is a decentralized blockchain protocol enabling a peer-to-peer marketplace for AI-driven drug discovery.

Vision

MolecuLayer is a decentralized blockchain protocol that revolutionizes drug discovery by enabling a peer-to-peer marketplace for machine learning inference and validation. By leveraging distributed GPU resources, MolecuLayer allows miners to process complex drug discovery prompts, validators to ensure solution quality, and researchers to access cutting-edge computational tools at reduced costs. Powered by the native MLYR token, MolecuLayer democratizes access to advanced AI-driven drug discovery, fostering innovation and collaboration in a transparent, secure, and community-driven ecosystem.

Architecture

Miners

GPU operators process drug discovery prompts off-chain using AI models of their choice. A default open-source model is provided for accessibility.

Validators

GPU operators verify the accuracy of miners' solutions, sharing a portion of mining rewards.

Researchers

Submit prompts and deposit bids in MLYR tokens or other cryptocurrencies to access computational resources.

Tokenomics

The MLYR token is the native cryptocurrency of MolecuLayer, with a maximum supply of 50 million tokens and a 4-year halving cycle.

Rewards: Miners and validators earn MLYR based on solution quality and validation accuracy.
Bids: Researchers deposit MLYR tokens to incentivize miners.
Governance: Token holders vote on protocol upgrades and validator penalties.
Staking: Validators stake MLYR tokens, with slashing for malicious behavior.

Token Distribution:

Mining/Validation	40%
Ecosystem	20%
Team	15%
Community	15%
Liquidity	10%

Roadmap

Q3 2025: Testnet launch with basic prompt processing and validation.

Q1 2026: Mainnet launch with support for plaintext and 3D molecule prompts.

Q3 2026: Integration of advanced models and governance features.

Q1 2027: Expansion to other scientific compute tasks.